The aim of this project organized by Drexel University (USA), Materials Research Centre and Science and Technology Center in Ukraine (STCU) was to develop and manufacture scalable pilot production line for MXene synthesis with controlled parameters, production capacity 100 g of MXene per a time.
MATERIAL WITNESSES — RESEARCHERS AROUND THE WORLD ARE DELVING INTO DREXEL’S 2D MXENE
10.02.2017 15:59 News - Science аnd Nanotechnology News
More than twenty 2D carbides, nitrides and carbonitrides of transition metals (MXenes) have been synthesized and studied, and dozens more predicted to exist. Highly electrically conductive MXenes show promise in electrical energy storage, electromagnetic interference shielding, electrocatalysis, plasmonics and other applications. The cost of producing the material is a key determinant in whether or not it’s viable to move forward with research. Each of these challenges is an important hurdle that MXene must overcome on the way to being commercially viable, according to Gogotsi. But the team has made promising strides in scaling up its production process while also improving quality control. While most nanomaterials are only available in “nano” quantities, Gogotsi’s lab can make as much as 100 grams of MXene at a time, using a reactor developed with the Materials Research Center in Ukraine. This means that one of the biggest obstacles is out of the way and, with the help of broadening research efforts, MXene could soon be a name in technology as well.
While most nanomaterials are only available in “nano” quantities, Gogotsi’s lab can make as much as 100 grams of MXene at a time, using a reactor developed with the Materials Research Center in Ukraine. While most nanomaterials are only available in “nano” quantities, Gogotsi’s lab can make as much as 100 grams of MXene at a time, using a reactor developed with the Materials Research Center in Ukraine.
“The fact that they can be produced in 100-gram quantities in the lab is a breakthrough that clearly shows that their practical applications are real,” Gogotsi said. Read More...
Source: https://newsblog.drexel.edu
MXenes potential applications include sensors, wound healing materials, and drug delivery systems. A recent study explored how different synthesis methods affect the safety and performance of MXenes. By comparing etching conditions and intercalation strategies, researchers discovered that fine-tuning the surface chemistry of MXenes plays a crucial role in improving biocompatibility. These results provide practical guidelines for developing safer MXenes and bring the field one step closer to real biomedical applications.
Exellent news, our joint patent application with Drexel University on highly porous MAX phase precursor for MXene synthesis published. Congratulations and thanks to all team involved!
Last Call! Have you submitted your abstract for IEEE NAP-2025 yet? Join us at the International Symposium on "The MXene Frontier: Transformative Nanomaterials Shaping the Future" – the largest MXene-focused conference in Europe this year! Final Submission Deadline: May 15, 2025. Don’t miss this exclusive opportunity to showcase your research and engage with world leaders in the MXene field!
We are excited to announce the publication of latest review article on MXenes in Healthcare. This comprehensive review explores the groundbreaking role of MXenes—an emerging class of 2D materials—in revolutionizing the fields of medical diagnostics and therapeutics. Read the full article here: https://doi.org/10.1039/D4NR04853A.
Congratulations and thank you to our collaborators from TU Wien and CEST for very interesting work and making it published! In this work, an upscalable electrochemical MXene synthesis is presented. Yields of up to 60% electrochemical MXene (EC-MXene) with no byproducts from a single exfoliation cycle are achieved.
Congratulations to all collaborators with this interesting joint work!
Thank you to our collaborators for the amazing joint work recently published in Graphene and 2D Nanomaterials about MXene–silk fibroin composite films aiming to develop materials with tunable electronic and thermal properties
Dr. Oleksiy Gogotsi, director of MRC and Carbon-Ukraine, innovative companies that are among the leaders on the world MXene market, visited 2024 MRS Fall Meeting & Exhibit. together with Dr. Maksym Pogorielov, Head of Advanced Biomaterials and Biophysics Laboratory, University of Latvia.
MRC and Carbon-Ukraine team visited the 3rd International MXene conference held at Drexel University on August 5-8, 2024. Conference brought together the best reserchers and leading experts on MXene field. 
Together with colleagues from the University of Latvia, MRC/Carbone Ukraine, Adam Mickiewicz University, University Clinic Essen, and others, we have developed a novel concept involving the binding of antibodies to MXenes. In our research, we utilized anti-CEACAM1 antibodies to develop targeted photo-thermal therapy for melanoma (in vitro), paving the way for future in vivo studies and clinical trials. For the first time, we demonstrate the feasibility of delivering MXenes specifically targeted to melanoma cells, enabling the effective ablation of cancer cells under near-infrared (NIR) light. This new technique opens up vast potential for the application of MXenes in cancer treatment, diagnostics, drug delivery, and many other medical purposes.
